sclc
sclc
1. Clinical summarization of 132 SCLC cases treated with therapy integrated Chinese and western medicine
132例小细胞肺癌中西医结合治疗临床总结
2. The one year survival rate in group A(16.7%) was lower than that in group B(40.0%) . Conclusion The general SCLC chemotherapy regimen is suitable for NSCLC patients with high serum NSE level.
1年生存率40.0%,两组差异有显著(P<0.05) 结论 血清NSE水平升高的晚期NACLC患者选用常用的SCLC化疗方案较为合适。
3. Not plasma but nuclear p21 WAF1/CIP1 expression was significantly different between SCLC and NSCLC,while neither of them was correlate with other clinical parameter of lung cancer.
2 .小细胞肺癌与非小细胞肺癌中核 p2 1 WAF1/ CIP1表达存在显著性差异 ( P<0 .0 0 5) ,浆 P2 1 WAF1/ CIP1则不存在显著性差异 P<0 .0 0 5)。
4. 2 No abnormal electrophysiological changes was appeared on 6 patients of 10 with only SCLC .
2在10例单纯SCLC患者中，6例EMG、NCV、SEP无明显异常。
5. Specific neuronal anti-Hu antibody for use in the early diagnosis of SCLC:
3特异性神经元抗一Hu抗体对SCLC早期诊断的价值
6. 40 cases of SCLC treated with CAO (CTX, ADM, VCR) orwith IAO (CTX substituted by IFO) had an average remission rate of 57.5% (IAO78.6%, CAO 46.2%).
40例SOLC用环磷酰胺、ADM和长春新?(CAO)或以异环磷酰胺替代环磷酰胺(IAO). 缓解率57.5%。
7. The other 16 cases (11 with NHL,3 HL,1 MM and 1 SCLC) were performed by APBSCT. CTX+G CSF+DXM were given to mobilize the peripheral stem cell ,followed by the conditioning regimen of CBV for NHL,CBM for MM,and CEP for SCLC.
APBSCT组 16例 (NHL 11例 ,HL 3例 ,MM1例 ,SCL C1例 )用 CTX+G- CSF+ DXM方案动员 ,NHL 采用 CBV方案预处理 ,MM采用 CBM处理 ,SCL C采用 CEP方案处理。
8. The positive rate of Bcl 2 protein expression in SCLC was significantly higher than that in NSCLC (P<0.05).
Bcl2蛋白阳性表达率在小细胞肺癌显著高于非小细胞肺癌(P<0.05)。
9. Keywords BST thin films;leakage current;temperature characteristics;space-charge-limit-current（SCLC）;
BST薄膜;漏电流;温度特性;空间电荷限制电流;
10. There were no expression of cerbB2 and nm23H1 oncoprotein in 10 small cell lung carcinoma (SCLC).
c?erbB?2与nm23?H1在10例小细胞肺癌（SCLC）中未见表达。
11. No SCLC was found to express Desmin and GFAP.
Desmin、GFAP未见表达。
12. KIT protein is expressed in SCLC, and its kinase actiity has been implicated in the pathophysiology of many tumours, including SCLC.
KIT蛋白在小细胞肺癌中表达，它的激酶活性与许多肿瘤的病理生理学都有联系，包括小细胞肺癌。
13. Therefore, combined detemination of MOC 31 and CD56 is more useful than that of single item in diagnosing SCLC.
MOC-31与CD56联合检测,对诊断SCLC更有意义。
14. SCLC large flake was extensive necrosis, blood vessel wall basophilic, NHL does not have this change;
SCLC呈大片状广泛坏死，血管壁嗜碱性，NHL没有此改变;
15. Median survival in the patients with SCLC was 3months, with NSCLC was 8. 5 months.
SCLC和NSCLC的中位生存期分别为3个月和8.5个月。
16. The HuD positive rate was 87.1% in SCLC with extensive stage higher than those of limited stage.
SCLC广泛期骨髓HuD阳性率 (85 .7% )高于局限期 (2 8.6% ) ,P <0 .0 5。
17. Prevalence of HuD in bone marrow in SCLC was higher than that in benign patients(57.1% vs 16.7%,P<0.05);
SCLC患者骨髓HuD阳性率 (5 7.1% )显著高于非肿瘤对照组 (16 .7% ) ,P <0 .0 5 ;
18. Elevated levels of IL-10 were found in SCLC group with respect to NSCLC. IL-12 from PBMC and AM were lower than that of adenocarcinoma, adenocarcinoma and squamous carcinoma separately.
SCLC组IL-10水平显著高于腺癌组及鳞癌组，而PBMC分泌的IL-12水平低于腺癌组，AM分泌的IL-12水平低于腺癌组及鳞癌组。
19. SSCC low differentiation, cancer cells small, granular nuclear chromatin, cell shape is similar with the SCLC.
SSCC分化较低，癌细胞较小，核染色质呈颗粒状，细胞形态上与SCLC有相似之处。
20. Compares with non-small cell lung cancer,small cell lung cancer (SCLC) generally has a more rapid doubling time,a higher growth fraction,and earlier development of widespread metastases.
与非小细胞肺癌相比较,小细胞肺癌具有更快的肿瘤倍增时间、快速生长以及易于早期转移的特点。
21. The pattern, structure and electrical property based on SCLC method of the films are discussed to seek for the relations of the film structure and the electrical property.
为了寻找薄膜结构和电学性质的关系,对薄膜的形貌、结构和基于SCLC方法的电学特性进行了探讨。
22. Surgical operation has little impact on long-term survival of SCLC patients.
以往认为小细胞肺癌的患者不适合手术,小细胞肺癌的主要治疗是化疗和放疗。
23. Patients with SCLC in excess of stage T2N0 do not benefit from surgical operation.
但临床分期超过T2N0的患者,手术无益于患者的长期生存。
24. Neuropsychologic testing was prospectively conducted before and after PCI to evaluate its effects on cognitive function in patients with SCLC.
分别在PCI前和后进行神经心理血的测试来评价它对SCLC患者的认知功能的影响。
25. the sera of 89% (16/18)patients of SCLC with PNSNS reacted at the final didutions of 1:1 000 to 1:64 000 ;
在16例(89%)伴PNSNS的SCLC患者血清中检测出特异性神经元抗体; 滴度为1:1 000一1:64 000;
26. study the anticancer action of BTW abstract inhuman SCLC and colon cancer HT29 on nude mice.
在人癌-裸鼠动物模型上,观察白头翁提取物对裸鼠接种的人小细胞肺癌、大肠癌HT29的抗癌作用;
27. The Rb gene abnormality was one of the hereditary factors associated with the occurrence of lung cancer, and the abnormal Rb gene was found in 90% of small cell lung cancer (SCLC) and 10 -30% of non - small cell lung cancer ( NSCLC).
在小细胞肺癌(SCLC)约90%，非小细胞肺癌(NSCLC)约10-30%存在Rb基因异常，Rb基因异常者因肺癌死亡的危险性比正常人高15倍，是肺癌发生的遗传因素之一。
28. Two kinds of barriers are presented in SIT, corresponding to channel voltage barrier control (CVBC) mechanism and space charge limited control (SCLC) mechanism respectively.
在漏压增长过程中，有两种势垒出现（沟道势垒和空间电荷势垒），它们分别对应于沟道势垒调制和空间电荷势垒调制模式。
29. The presence of stable disease in a patient with SCLC oer six cycles of therapy is ery encouraging," he continued.
在经过六期的化疗后，小细胞肺癌患者病情稳定期的出现是很鼓舞人的。”
30. The pIgR/SC expression was found in 66.3% of SCC, 34.4% and 4.3% of ADC and SCLC specimens respectively (P<0.001).
在肺癌组织不同病理类型之间的差异具有统计学意义(P<0.001)，其表达的阳性率从高到低依次为：鳞癌66.3%>腺癌34.4%>小细胞肺癌4.3%。
31. Keywords Peripheral blood stem cell rescue Mobolization High dose chemotherapy SCLC;
外周血干细胞解救;动员;高剂量化疗;小细胞肺癌;
32. Among 320 patients analyzed,adenocarcinoma accounted for 48.3%,squamous cell carcinoma 16.6% and SCLC 9.1%;
女性肺癌中病理类型分别为腺癌48.3% ,鳞癌16.6% ,小细胞肺癌9.1%。
33. Without appropriate treatment for SCLC, all reported patients with SCLC and OMS have died of complications of OMS within 3 months of diagnosis.
如果没有适当的治疗，所有的SCLC和OMS报告病例在确诊后3个月内死于OMS的并发症。
34. small cell lung cancer (SCLC)
小细胞肺癌
35. Although the incidence of pancreatic metastasis from SCLC is rare, the early definite diagnosis and active treatment is needed.
小细胞肺癌发生胰腺转移临床上少见,但应争取早期明确诊断和积极治疗。
36. Small cell lung cancer(SCLC) is a type of lung cancer classified by pathobiology.SCLC constitutes approximately 20% of all lung cancer.
小细胞肺癌是肺癌的一种病理学分类,约占肺癌的20%,小细胞肺癌的治疗方案一般为化疗和放疗联合方案;
37. Clinical Diagnostic Value of CT Scan and Serum Tumor Markers Determination for SCLC
小细胞肺癌的CT扫描和分子标志物检测的临床应用研究
38. The mRNA levels of this gene were determined in SCLC cell line SH77 ,big cell lung cancer cell line H460,lung adenocarcinoma cell line SPC A 1 and SPC A 1/CDDP using semi quantitative RT PCR assay.
应用半定量RT-PCR方法检验小细胞肺癌SH77、大细胞肺癌H460、肺腺癌SPC-A-1和SPC-A-1/cDDP等细胞株中该基因mRNA的表达。
39. Abstract: Paraneoplastic opsoclonus-myoclonus syndrome (OMS) is associated with small cell lung cancer (SCLC) in adults.
成年人的副肿瘤性眼阵挛-肌阵挛综合征（OMS）与小细胞肺癌（SCLC）有关。
40. We report a case of combined SCLC of the lung, including adenocarcinoma and spindle-shaped cell tumor, with an unusual initial presentation.
我们提出一个含有小细胞癌、腺癌及纺锥型肿瘤三成份的合并型小细胞肺癌病例及其不寻常的软组织转移表现。
41. Compares with non-small cell lung cancer, small cell lung cancer (SCLC) generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases.
摘要与非小细胞肺癌相比较，小细胞肺癌具有更快的肿瘤倍增时间、快速生长以及易于早期转移的特点。
42. Methods Expression of P-gp, p53, and Bcl-2 proteins was examined in 8 NSCLC surgical specimens and 7 SCLC bronchoscopically biopsied specimens using postembedding PAG immunolabelling technique for electron microscopy.
方法 8例非小细胞肺癌 (NSCLC)手术标本和 7例小细胞肺癌 (SCLC)经支气管镜活检标本 ,用免疫电镜方法包埋后 ,以PAG标记抗体方法检测P gp、p5 3蛋白、Bcl 2蛋白的表达。
43. Methods The clinical data of 29 cases with bone marrow metastases from SCLC were retrospectively analyzed by statistic software package of SPSS 10.0 for prognostic factors.
方法回顾性分析29例SCLC骨髓转移病例的临床资料,应用SPSS10.0软件包分析其预后影响因素。
44. Methods: 1 Electron observation: 4 cases of SCLC and 2 cases of SCC were detected by electron microscope to observe the distribution of neuroendocrine granules.
方法：1电镜观察：取新鲜肺小细胞癌4例，肺鳞状细胞癌2例，送电镜室经制片、染色后，进行电镜观察。电镜下观察肺小细胞癌和鳞状细胞癌中神经内分泌颗粒的分布。
45. advanced non-small cell lung cancer (NSCLC) and advanced small cell lung cancer (SCLC)
晚期非小细胞肺癌和晚期小细胞肺癌
46. This project is concentrated on the research about the combining pollution of pesticides with novel Soil Column Liquid Chromatography (SCLC) and frontal analysis.
本课题利用所发展的土壤柱色谱技术，将液相色谱前沿分析方法应用于土壤复合污染研究。
47. The highest response rate was noted in malignant lymphomas being 83.8%,followed by SCLC,73.9%.
毒副反应以骨髓抑制、胃肠反应、脱发为多见。
48. Detection of specific neuronal anti-Hu antibody in patients of SCLC and its clinical value
特异性神经元抗-Hu抗体在小细胞肺癌患者血清中的检测及意义
49. Density of defect states in low-k porous SiO_2:F film researched by SCLC method
用SCLC法研究低k多孔SiO_2:F薄膜的隙态密度
50. Methods:Serum level of NSE and CEA(with CLIA)were determined in 45 patients with SCLC and 50 controls(with benign pneumonia).99mTc bone scan with SPECT was performed in all the patients with SCLC.
用单光子发射型计算机断层(SPECT)对45例小细胞肺癌(SCLC)患者进行全身骨显像,同时测定NSE、CEA。
51. SIP-IFTZ is suppositional overseas area, thus cargos from SCLC to SIP-IFTZ are considered as export, the shipper could get VAT rebate, and they can enjoy the declaration convenience.
由于苏园综保区似同境外，南华物流园转过来的货物可以享受入区退税，给华南供应商的报关供了天时、地利、人和的条件。
52. The main pathology type is small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC).
病理类型以小细胞肺癌和非小细胞肺癌为主。
53. Objective: To summarize and analyze the CT features , approach and result of pathologic diagnosis in small cell lung cancer (SCLC), and study the correlation of radiologic and pathologic basis.
目的:总结分析小细胞肺癌的CT表现特点、病理诊断途径及其结果,以加强对本病的病理基础与影像表现关系的认识。
54. Objective: To evaluate the diagnostic significance of CT findings in small cell lung cancer (SCLC).
目的:探讨小细胞肺癌(SCLC)的CT表现与诊断。
55. Objective To discuss the correlation of CT appearances and the angiogenesis(VEGF,MVD) in small cell lung cancer(SCLC).
目的探讨小细胞肺癌(SCLC)的CT征象和血管内皮生长因子(VEGF)、微血管密度(MVD)的相关性。
56. Objective To observe the relation of traditional Chinese medicine (TCM) syndromes of advanced small cell lung cancer (SCLC) and quality of life (QOL).
目的探讨晚期小细胞肺癌的中医证候与生存质量的关系。
57. Objective To investigate the expression of osteopontin(OPN) and its correlation with lymph node metastases and pathologic features of small cell lung cancer(SCLC).
目的研究骨桥蛋白(OPN)在小细胞肺癌(SCLC)中的表达及其与肺癌转移的关系。方法应用免疫组化法检测23例患者肺癌组织中OPN的表达,以18例正常肺组织作为对照。
58. Objective The aim of this study is to evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced SCLC.
目的观察伊立替康联合顺铂方案治疗复治性晚期小细胞肺癌的疗效和安全性。
59. Aim To evaluate the therapeutic efficiency of Ad-hTRAIL (the replication-defective adenovirus expressing recombinant human TRAIL gene) on human small cell lung cancer (SCLC) cell line H446 in vitro.
目的评价携带人TRAIL基因的腺病毒载体对人小细胞肺癌细胞株H446的基因治疗功效。
60. Purpose To discuss the relationship between the change of p53 gene and the expression of murine double minute 2 (mdm 2) gene protein in small cell lung cancer (SCLC).
目的：探讨肺小细胞癌（ S C L C） 的p53 基因改变与mdm?2 基因蛋白表达的关系。
61. space-charge limited currents (SCLC)
空间电荷限制电流
62. space charge limited current ( SCLC )
空间电荷限制电流（SCLC）
63. Results:Among 320 patients analyzed,adenocarcinoma accounted for 48.3%,squamous cell carcinoma 16.6% and SCLC 9.1%;
结果:女性肺癌中病理类型分别为腺癌48.3%,鳞癌16.6%,小细胞肺癌9.1%。
64. Southern, Northern and Western blot were done to exam PTEN abnormality in one NSCLC and three SCLC cell lines.
结果有正常配对的肺癌新鲜标本45.8%（11/24）有PTEN位点的杂合性丢失；
65. The results showed that the expression of CD44s or CD44v6 in 41 non-small cell lung cancer (NSCLC) cases were 70.7% and 9.7%, respectively, but no CD44s or CD44v6 expressed in 15 small cell lung cancer(SCLC)cas- es.
结果：41例非小细胞肺癌（NSCLC）包括鳞癌、腺癌、大细胞癌的 CC44h4s表达率为 70.7%， CIM4v6的表达率为9.7%，而15例小细胞肺癌（SCLC）无一例表达 CD44s和 CD44v6。
66. Conclusion There are the overexpression of C-MYC and mutated P53 protein in SCLC,which suggests that they may play an important role in the occurrence development of SCLC.
结论SCLC存在C-MYC、突变型P53蛋白过度表达，提示它们在SCLC发生、发展过程中可能起着重要作用。
67. CONCLUSION: KIT protein is expressed in a high percentage of SCLC tumours. In our study population, howeer, the expression of KIT had no significant impact on surial.
结论：KIT蛋白在小细胞肺癌的肿瘤组织中呈高表达。尽管如此，在此次研究的人群中，KIT的表达情况对生存率无明显影响。
68. Conclusion: Being the tumor markers with high specificity and sensitivity, NSE and SCLC show great reference significance in detection of lung cancer.
结论：NSE是对小细胞肺癌具有高特异性和高敏感性的肿瘤标志物，在小细胞肺癌诊断上具有重要的参考意义。
69. CONCLUSIONS.Neurocognitive testing demonstrated that a substantial portion of patients with SCLC had impaired brain functioning at baseline.
结论：神经认知测试证实SCLC患者的脑功能受到影响。
70. But the NSE in blood serum of SCLC patients was significantly higher (73. 3%) than those of NSCLC patients (27. 8%) (P<0. 01) .
而血清NSE升高以小细胞肺癌为主,阳性率为73.3%,明显高于非小细胞肺癌组27.8%(P<0.01);
71. Clinic diagnosis value of CT scan and serum tumor markers determination for SCLC
联合应用CT和血清肿瘤标志物检测诊断小细胞肺癌的研究
72. Keywords Poly（phenyl acetylene）;Voltage ampere characteristics;Ohmic conductivity;Space charge limited current（SCLC）;Gauss distribution trap energy;
聚苯乙炔;伏-安特性;欧姆电导;空间电荷限制电流;高斯分布陷阱能级;陷阱态密度;
73. BACKGROUND: Small cell lung cancer (SCLC) is a ery aggressie disease, with poor surial rates despite standard treatment with combination chemotherapy with or without radiotherapy.
背景：小细胞肺癌(SCLC)是一种非常有侵袭性的疾病，虽然通过标准治疗加上联合化疗再加上或不加放射治疗，存活率不高。
74. BACKGROUND.The use of prophylactic cranial irradiation (PCI) in patients with small cell lung cancer (SCLC) has been tempered by fears of detrimental effects on cognitive function.
背景：由于对认知功能的不利影响，小细胞肺癌（SCLC）患者的预防性头颅放疗（PCI）运用得少了。
75. STUDY OF HIGH-DOSE CHEMOTHERAPY COMBINE AUTOLOGOUS PERIPHERAL BLOOD STEM CELL SUPPORT ON TREATMENT OF SCLC
自体外周血干细胞支持高剂量化疗治疗小细胞肺癌的研究
76. The Expression of Efflux Pumps Related to Resistance to Anticancer Drugs(Pgp, MRP, LRP) in Human SCLC Cancer Specimens and Modulation of Multidrug Resistance in Human SCLC Cell Line GLC4/ADR by Inhibition of MRP with Antisense MRP RNA
药物泵（PgP、MRP，LRP）在人SCLC癌组织中的表达及反义MRP RNA对耐ADR人SCLC细胞株耐药性的调节
77. While some tumours treated were indolent, others such as extensie SCLC were ery aggressie.
虽然有些肿瘤的治疗是无效的，其它如广泛的小细胞肺癌有着很强的侵袭性。
78. Of the 70 lung cancers, 29 cases (49.2%) were positive for MDRl expression in NSCLCs and 2cases (18.2%) in small cell lung carcinoma(SCLC);
表达情况:70例肺癌中,59例非小细胞肺癌出现MDR1过度表达的有29例(49.2%),11例小细胞肺癌(SCLC)中MDR1过度表达的有2例(18.2%),两者有显著差异(P<0.05);
79. To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC).
观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
80. The purpose of this study was to ealuate the prealence of KIT expression in patients with SCLC and its prognostic alue.
这项研究的目的是评估在小细胞肺癌患者中KIT表达的普遍性和它的预后价值。
